🔗 Share this article

Treasury head Reeves has stated she is preparing "specific steps to address household expense challenges" in next month's Budget.

During an interview with media outlets, she noted that lowering price rises is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Energy Cost Measures

Sources suggest the administration could take action to bring down energy bills, for example by reducing the current 5% rate of VAT applied on energy supplies.

Another option is to reduce some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Analyst Expectations

The government will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for such actions.

The expectation from the majority of experts is that Reeves will have to declare tax increases or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on Thursday, calculations suggested there was a £22 billion shortfall for the chancellor to address, which is at the more modest range of projections.

"There's a collective responsibility between the Bank of England and the government to bear down further on some of the sources of inflation," Reeves told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and International Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with rising geopolitical and commercial issues for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

Global Economic Tensions

Referring to concerns about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always come first."

Recent declaration by China to tighten trade restrictions on rare earths and other resources that are essential for advanced tech production led American leader Donald Trump to suggest an additional 100% tariff on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese move "economic coercion" and "a global supply chain control attempt."

Asked about accepting the American proposal to participate in its conflict with China, the Chancellor said she was "very concerned" by China's actions and called on the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the global economy and causes additional headwinds."

"I believe there are sectors where we should confront China, but there are also valuable chances to sell into China's economy, including financial services and other sectors of the economy. We've got to get that balance correct."

The Treasury chief also confirmed she was working with other major economies "on our own critical minerals plan, so that we are more independent."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the price the NHS pays for drugs could rise as a consequence of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said recently that they are either pausing or abandoning operations in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the Science Minister said the cost the health service pays for medicines would need to go up to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor told the BBC: "We have seen because of the cost structure, that drug testing, new drugs have not been available in the United Kingdom in the extent that they are in other European countries."

"The objective is to guarantee that people getting treatment from the National Health Service are can receive the best essential treatments in the globe. And so we are examining these issues, and... looking to secure more funding into the UK."